Trial intelligence / Profile preview

Comparison of outcomes and survival between neoadjuvant chemotherapy and primary surgery in advanced ovarian, fallopian tube, and peritoneal cancer

TCTR20220225007Completed

Sponsor
Surin Hospital Cancer Center
Start
Jan 2011
Countries
1
01

Overview

Open-label trial in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) (2 arms), sponsored by Surin Hospital Cancer Center. Started Jan 2011; status: completed.

02

Conditions

ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)

Beyond the preview

Go deeper on TCTR20220225007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220225007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call